Chat with us, powered by LiveChat

Hyaluronic Acid Market (Type - Single Injection, Three Injection, and Five Injection; Application - Osteoarthritis, Ophthalmic, Dermal Fillers, and Vesicoureteral Reflux): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

Hyaluronic Acid Market (Type - Single Injection, Three Injection, and Five Injection; Application - Osteoarthritis, Ophthalmic, Dermal Fillers, and Vesicoureteral Reflux): Global Industry Analysis, Trends, Size, Share and Forecasts to 2026

Report Code: HC0045 Category: Healthcare & Medical Devices Published: December, 2020

A recent report published by Infinium Global Research on the hyaluronic acid market provides an in-depth analysis of segments and sub-segments in the global as well as regional hyaluronic acid market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional hyaluronic acid market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global hyaluronic acid market. According to the report, the global hyaluronic acid market is projected to grow at a CAGR of 8.3% over the forecast period of 2020-2026.


Market Insight

Hyaluronic acid, also known as hyaluronan is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. Its function in the body is to bind water and to lubricate movable parts of the body, such as joints and muscles. Its consistency and tissue-friendliness allow it to be beneficial in skin-care products as an excellent moisturizer. As it is one of the most hydrophilic molecules in nature with numerous benefits for the human body it can be considered as a natural moisturizer. Hyaluronic acid helps in providing normal joint cushioning. With these advantages, hyaluronic acid exhibits a wide range of applications in ophthalmology, dermatology, rheumatology, orthopedic surgery, otolaryngology, plastic surgery, drug delivery, and wound healing.

 

Currently, as the entire health care system is primarily focused on treating COVID-19 patients and developing vaccines for this virus, the major healthcare service providers across the globe are projected to experience significant growth during the 2020 COVID-19 outbreak. The novel coronavirus (COVID-19) pandemic is rapidly changing the way of treating patients and working of R&D communities, which have moderately affected the hyaluronic acid market. However, several health benefits associated with hyaluronic acid such as moisture retention, faster wound healing, relief from joint pain and preservation of bone strength increases the demand during the pandemic. Along with this, increasing incidences of osteoarthritis, ulcers, and gingivitis propelling the market growth.

 

The global rise in the base geriatric population, increasing incidence of osteoarthritis, ulcers, and gingivitis, and rising demand for cosmetic procedures related to the anti-aging processes are the key driving factors that are expected to expand the hyaluronic acid market significantly. Moreover, the growing patients’ and healthcare professionals’ preference towards minimally invasive surgical procedures coupled with favorable reimbursement policies is further driving the hyaluronic acid market. Increasing awareness about health and beauty standards among the population is further propelling the market growth. However, the availability of other cost-effective treatment alternatives could hinder the market growth. Nevertheless, the introduction of newer technologies into the market and many product approvals witnessing huge market growth in the forecast period.

 

Among the geographies, the North American region is expected to hold the largest share in the global hyaluronic acid market. The U.S. is the major contributing country in the North American region. Factors such as increasing demand for minimally invasive surgeries and increasing geriatric population along with rising demand for anti-aging treatments escalate the market growth in this region. Further, growing R&D activities in this region contribute to the market growth. Additionally, the Asia Pacific region is expected to witness the highest growth rate during the projection period, due to a rapidly growing population and increasing consumer awareness about minimally invasive treatments.

 

Segment Covered

The report on global hyaluronic acid market covers segments such as type, and application. On the basis of type, the sub-markets include single injection, three injection, and five injection. On the basis of application, the sub-markets include osteoarthritis, ophthalmic, dermal fillers, and vesicoureteral reflux.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Allergan Inc, Sanofi S.A., Genzyme Corporation, F.Hoffmann-La Roche AG, Biomet Biologics, LLC, Smith & Nephew PLC, Ferring Pharmaceuticals Inc., Anika Therapeutics Inc., Seikagaku Corp., and Salix Pharmaceuticals, Inc..

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the hyaluronic acid market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.